(Q68768839)
Statements
A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression (English)
L J Old
H F Oettgen
P Garin-Chesa
D A Scheinberg
D J Straus
S D Yeh
C Divgi
M Graham
K Pentlow